Malgorzata Sztiller-Sikorska

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Estrogen Receptor

Childhood Cancer

Endoplasmic Reticulum Stress

Top Venues

Apoptosis : an international journal on programmed cell death

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Mariusz L Hartman, Malgorzata Sztiller-Sikorska, Anna Gajos-Michniewicz, Małgorzata Czyż
Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity. Cells 9 (1) (2020)
Malgorzata Sztiller-Sikorska, Małgorzata Czyż
Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Aleksandra Mielczarek-Lewandowska, Malgorzata Sztiller-Sikorska, Marta Osrodek, Małgorzata Czyż, Mariusz L Hartman
17-Aminogeldanamycin selectively diminishes IRE1α-XBP1s pathway activity and cooperatively induces apoptosis with MEK1/2 and BRAFV600E inhibitors in melanoma cells of different genetic subtypes. Apoptosis : an international journal on programmed cell death 24 (7-8) (2020)
Markus Düchler, Liliana Czernek, Lukasz Peczek, Wojciech Cypryk, Malgorzata Sztiller-Sikorska, Małgorzata Czyż
Melanoma-Derived Extracellular Vesicles Bear the Potential for the Induction of Antigen-Specific Tolerance. Cells 8 (7) (2019)